Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Antibody response to SARS-CoV-2 infection and BNT162b2 vaccine in Israel

View ORCID ProfileGuy Shapira, Ramzia Abu Hamad, View ORCID ProfileChen Weiner, Nir Rainy, View ORCID ProfileReut Sorek-Abramovich, Patricia Benveniste-Levkovitz, Adina Bar Chaim, View ORCID ProfileNoam Shomron
doi: https://doi.org/10.1101/2021.07.07.21259499
Guy Shapira
1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guy Shapira
Ramzia Abu Hamad
2Shamir Medical Center, Be’er Yaacov, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Weiner
1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Shamir Medical Center, Be’er Yaacov, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chen Weiner
Nir Rainy
2Shamir Medical Center, Be’er Yaacov, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reut Sorek-Abramovich
2Shamir Medical Center, Be’er Yaacov, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Reut Sorek-Abramovich
Patricia Benveniste-Levkovitz
2Shamir Medical Center, Be’er Yaacov, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adina Bar Chaim
2Shamir Medical Center, Be’er Yaacov, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: adinab@shamir.gov.il nshomron@tauex.tau.ac.il
Noam Shomron
1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noam Shomron
  • For correspondence: adinab@shamir.gov.il nshomron@tauex.tau.ac.il
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Neutralizing antibodies targeting the Spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) block viral entry to host cells, preventing disease and further spread of the pathogen. The presence of SARS-CoV-2 antibodies in serum is a reliable indicator of infection, used epidemiologically to estimate the prevalence of infection and clinically as a measurement of an antigen-specific immune response. In this study, we analyzed serum Spike protein-specific IgG antibodies from 26,170 samples, including convalescent individuals who had coronavirus disease 2019 (COVID-19) and recipients of the BNT162b2 vaccine. We find distinct serological patterns in COVID-19 convalescent and vaccinated individuals, correlated with age and gender and the presence symptoms.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was not supported by any specific grant and required no additional funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Review Board of Shamir (Assaf Harofe) Medical Center and followed the tenets of the Declaration of Helsinki (146-21-asf).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data collected for this study is protected under patient confidentiality laws.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 08, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Antibody response to SARS-CoV-2 infection and BNT162b2 vaccine in Israel
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antibody response to SARS-CoV-2 infection and BNT162b2 vaccine in Israel
Guy Shapira, Ramzia Abu Hamad, Chen Weiner, Nir Rainy, Reut Sorek-Abramovich, Patricia Benveniste-Levkovitz, Adina Bar Chaim, Noam Shomron
medRxiv 2021.07.07.21259499; doi: https://doi.org/10.1101/2021.07.07.21259499
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Antibody response to SARS-CoV-2 infection and BNT162b2 vaccine in Israel
Guy Shapira, Ramzia Abu Hamad, Chen Weiner, Nir Rainy, Reut Sorek-Abramovich, Patricia Benveniste-Levkovitz, Adina Bar Chaim, Noam Shomron
medRxiv 2021.07.07.21259499; doi: https://doi.org/10.1101/2021.07.07.21259499

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)